Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Alzheimer Disease and Associated Disorders|October 15, 1998
No association between familial Alzheimer disease and cytochrome P450 polymorphismsH Yamada, M L Dahl, M Viitanen, et al.
Clinical Pharmacology and Therapeutics|May 20, 1998
10-Hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genesP Dalén, M L Dahl, M L Bernal Ruiz, et al.
Psychopharmacology|January 1, 1991
Treatment of depression with E-10-hydroxynortriptyline--a pilot study on biochemical effects and pharmacokineticsC Nordin, L Bertilsson, M L Dahl, et al.
Scandinavian Journal of Infectious Diseases|October 28, 1998
Antibiotic use in 3 European university hospitalsR A Kiivet, M L Dahl, A Llerena, et al.
Psychiatric Genetics|June 13, 1998
Lack of association between debrisoquine 4-hydroxylase (CYP2D6) gene polymorphisms and schizophreniaE G Jönsson, M L Dahl, H K Roh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 10, 1998
1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humansB Eiermann, P O Edlund, A Tjernberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993
Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquineI Johansson, E Lundqvist, L Bertilsson, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Nonlinearity of amoxicillin absorption kinetics in humanG Paintaud, G Alván, M L Dahl, et al.
Psychopharmacology|January 20, 2000
Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidoneM G Scordo, E Spina, G Facciolà, et al.
Biochemical and Biophysical Research Communications|January 28, 1999
Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish populationU Yasar, E Eliasson, M L Dahl, et al.
Pageof 11